CIAM
SGMT icon

Caitong International Asset Management’s Sagimet Biosciences SGMT Stock Holding History

Caitong International Asset Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,194
Closed -$3.89K – 2430
2025
Q1 		$3.89K Buy
1,194
+523
+78% +$2.19K ﹤0.01% 1097
2024
Q4 		$3.02K Buy
+671
New +$3.4K ﹤0.01% 1108

Other funds holding SGMT

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return

Caitong International Asset Management's SGMT Position: Q2 2025 in Review

Caitong International Asset Management sold out of Sagimet Biosciences (SGMT) in Q2 2025, closing a stake of 1,194 shares — an estimated $3.89K sold.

Caitong International Asset Management first reported a position in SGMT in Q4 2024 and held it in 2 quarters. The position peaked at $3.89K in Q1 2025. 67 funds tracked by Wall St. Rank hold SGMT as of Q2 2025.

  • Caitong International Asset Management reported no remaining Sagimet Biosciences position as of Q2 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 1,194 Sagimet Biosciences shares in Q2 2025, an estimated $3.89K.
  • Caitong International Asset Management first reported a position in Sagimet Biosciences in Q4 2024 and held it in 2 quarters.
  • Caitong International Asset Management's Sagimet Biosciences position peaked at $3.89K in Q1 2025.
  • 67 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2025.

Based on Caitong International Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.